238 related articles for article (PubMed ID: 23272696)
1. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol.
Wu J; Powell F; Larsen NA; Lai Z; Byth KF; Read J; Gu RF; Roth M; Toader D; Saeh JC; Chen H
ACS Chem Biol; 2013 Mar; 8(3):643-50. PubMed ID: 23272696
[TBL] [Abstract][Full Text] [Related]
2. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase.
Ninomiya-Tsuji J; Kajino T; Ono K; Ohtomo T; Matsumoto M; Shiina M; Mihara M; Tsuchiya M; Matsumoto K
J Biol Chem; 2003 May; 278(20):18485-90. PubMed ID: 12624112
[TBL] [Abstract][Full Text] [Related]
3. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.
Hrabe JE; O'Leary BR; Fath MA; Rodman SN; Button AM; Domann FE; Spitz DR; Mezhir JJ
Redox Biol; 2015 Aug; 5():319-327. PubMed ID: 26114584
[TBL] [Abstract][Full Text] [Related]
4. TGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage.
Zhang D; Yan H; Li H; Hao S; Zhuang Z; Liu M; Sun Q; Yang Y; Zhou M; Li K; Hang C
J Biol Chem; 2015 Aug; 290(32):19900-9. PubMed ID: 26100626
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of hyperthermia-induced apoptosis by 5Z-7-oxozeaenol, a TAK1 inhibitor, in A549 cells.
Li P; Zhao QL; Jawaid P; Rehman MU; Sakurai H; Kondo T
Cell Stress Chaperones; 2016 Sep; 21(5):873-81. PubMed ID: 27448221
[TBL] [Abstract][Full Text] [Related]
6. Synergistic action of 5Z-7-oxozeaenol and bortezomib in inducing apoptosis of Burkitt lymphoma cell line Daudi.
Zhang J; Li B; Wu H; Ou J; Wei R; Liu J; Cai W; Liu X; Zhao S; Yang J; Zhou L; Liu S; Liang A
Tumour Biol; 2016 Jan; 37(1):531-9. PubMed ID: 26227222
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor β-activated kinase 1 inhibitor suppresses the proliferation in triple-negative breast cancer through TGF-β/TGFR pathway.
Zhang L; Fu Z; Li X; Tang H; Luo J; Zhang D; Zhuang Y; Han Z; Yin M
Chem Biol Drug Des; 2017 Sep; 90(3):450-455. PubMed ID: 28224764
[TBL] [Abstract][Full Text] [Related]
8. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis.
Guan S; Lu J; Zhao Y; Woodfield SE; Zhang H; Xu X; Yu Y; Zhao J; Bieerkehazhi S; Liang H; Yang J; Zhang F; Sun S
Oncotarget; 2017 May; 8(20):33666-33675. PubMed ID: 28430599
[TBL] [Abstract][Full Text] [Related]
9. Isolation, semisynthesis, covalent docking and transforming growth factor beta-activated kinase 1 (TAK1)-inhibitory activities of (5Z)-7-oxozeaenol analogues.
Fakhouri L; El-Elimat T; Hurst DP; Reggio PH; Pearce CJ; Oberlies NH; Croatt MP
Bioorg Med Chem; 2015 Nov; 23(21):6993-9. PubMed ID: 26481152
[TBL] [Abstract][Full Text] [Related]
10. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy.
Fan Y; Cheng J; Vasudevan SA; Patel RH; Liang L; Xu X; Zhao Y; Jia W; Lu F; Zhang H; Nuchtern JG; Kim ES; Yang J
Apoptosis; 2013 Oct; 18(10):1224-34. PubMed ID: 23700229
[TBL] [Abstract][Full Text] [Related]
11. Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization.
Wang JH; Tseng CL; Lin FL; Chen J; Hsieh EH; Lama S; Chuang YF; Kumar S; Zhu L; McGuinness MB; Hernandez J; Tu L; Wang PY; Liu GS
Theranostics; 2022; 12(2):657-674. PubMed ID: 34976206
[No Abstract] [Full Text] [Related]
12. TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity.
van Caam A; Madej W; Garcia de Vinuesa A; Goumans MJ; Ten Dijke P; Blaney Davidson E; van der Kraan P
Arthritis Res Ther; 2017 May; 19(1):112. PubMed ID: 28569204
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of 2-cyanoacrylamide derivatives tethered to imidazopyridine as TAK1 inhibitors.
Kang SJ; Lee JW; Song J; Park J; Choi J; Suh KH; Min KH
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1928-1936. PubMed ID: 33086897
[TBL] [Abstract][Full Text] [Related]
14. Blockade of transforming growth factor-beta-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade.
Choo MK; Kawasaki N; Singhirunnusorn P; Koizumi K; Sato S; Akira S; Saiki I; Sakurai H
Mol Cancer Ther; 2006 Dec; 5(12):2970-6. PubMed ID: 17172402
[TBL] [Abstract][Full Text] [Related]
15. TAK1 signaling activity links the mast cell cytokine response and degranulation in allergic inflammation.
Watson CJF; Maguire ARR; Rouillard MM; Crozier RWE; Yousef M; Bruton KM; Fajardo VA; MacNeil AJ
J Leukoc Biol; 2020 Apr; 107(4):649-661. PubMed ID: 32108376
[TBL] [Abstract][Full Text] [Related]
16. Targeting of TGF-β-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer.
Huang HL; Chiang CH; Hung WC; Hou MF
Oncotarget; 2015 Jan; 6(2):995-1007. PubMed ID: 25557171
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of transforming growth factor beta-activated kinase 1 confers neuroprotection after traumatic brain injury in rats.
Zhang D; Hu Y; Sun Q; Zhao J; Cong Z; Liu H; Zhou M; Li K; Hang C
Neuroscience; 2013 May; 238():209-17. PubMed ID: 23485590
[TBL] [Abstract][Full Text] [Related]
18. TAK1 inhibition for treatment of cerebral ischemia.
Ridder DA; Schwaninger M
Exp Neurol; 2013 Jan; 239():68-72. PubMed ID: 23022457
[TBL] [Abstract][Full Text] [Related]
19. Suppression of monosodium urate crystal-induced inflammation by inhibiting TGF-β-activated kinase 1-dependent signaling: role of the ubiquitin proteasome system.
Singh AK; Haque M; O'Sullivan K; Chourasia M; Ouseph MM; Ahmed S
Cell Mol Immunol; 2021 Jan; 18(1):162-170. PubMed ID: 31511642
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of transforming growth factor-β-activated kinase 1 promotes taxol efficacy in ovarian cancer cells.
Bo L; Cui H; Fang Z; Qun T; Xia C
Biomed Pharmacother; 2016 Dec; 84():917-924. PubMed ID: 27764753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]